Janus-kinase Inhibitors in Pathogenesis and Management of Chronic Urticaria: A Review of the Literature
Background: Chronic urticaria is a long-lasting condition, sometimes with serious comorbidities, severely affecting the quality of life, which makes the patients seek efficient therapies to achieve sustained remissions. The complex nature of urticaria greatly complicates the patients’ responses to a...
Main Authors: | Sepideh Darougar, Seyed Karen Hashemitari, Sara Montazeri Namin |
---|---|
Format: | Article |
Language: | English |
Published: |
Mazandaran University of Medical Sciences
2023-04-01
|
Series: | Journal of Pediatrics Review |
Subjects: | |
Online Access: | http://jpr.mazums.ac.ir/article-1-475-en.pdf |
Similar Items
-
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
by: Nem Kumar Jain, et al.
Published: (2023-03-01) -
Potential Use of Janus Kinase Inhibitors in the Treatment of Systemic Lupus Erythematosus
by: Huo R, et al.
Published: (2023-04-01) -
The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current Insights
by: Eric Toussirot
Published: (2022-02-01) -
Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
by: Izabella Ryguła, et al.
Published: (2023-12-01) -
Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021-10-01)